Company Filing History:

12 out of 12,157

Bayer Aktiengesellschaft

patents

1 out of 4,177

Abbott Laboratories Corporation

patents

1 out of 832,680

Other

patents

Years Active: 1992-1998

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5712417 - Inhibitors of retroviral proteases (1998-01-27),

2. 5646121 - Pseudopeptides with antiviral activity (1997-07-08),

3. 5633231 - Valine-containing pseudopeptides with antiviral activity (1997-05-27),

4. 5605926 - Trifluoromethyl-containing pseudopeptides active against retroviruses (1997-02-25),

5. 5571921 - Substituted (2-oxo-1-benzimidazolinyl)-peperidines, process for their (1996-11-05),

6. 5492918 - Use of substituted chromans, some of which are known, as medicaments, (1996-02-20),

7. 5492896 - Pseudopeptides having an antiviral action (1996-02-20),

8. 5457108 - 5-oxo-dibenzo[a,d]cyclohepta-1,4-dienes (1995-10-10),

9. 5430151 - Trifluoromethyl-containing pseudopeptides active against retroviruses (1995-07-04),

10. 5424426 - Dithiolanylglycine-containing HIV protease inhibitors of the (1995-06-13),

11. 5364931 - Phosphonate-containing pseudopeptides of the hydroxyethylamine and (1994-11-15),

12. 5162538 - Antiviral new peptides (1992-11-10),

13. 5147865 - Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the (1992-09-15),

14. 5145951 - Peptides retroviral protease inhibitors comprising (1992-09-08),

Title: The Innovative Journey of Jutta Hansen

Introduction

Jutta Hansen, an esteemed inventor based in Wuppertal, Germany, has made remarkable contributions to the field of biochemistry through her innovative work. With a total of 14 patents to her name, her inventions primarily focus on antiviral compounds and their applications.

Latest Patents

Among her latest patents are groundbreaking inventions aimed at combating retroviral infections. One notable patent, titled "Inhibitors of retroviral proteases," relates to specific compounds that aim to inhibit the activity of retroviral proteases. This invention details a process for their preparation and outlines their potential use in therapeutic applications. Additionally, Hansen has introduced pseudopeptides with antiviral activity, where she presents novel compounds designed to target cytomegaloviruses, enhancing the arsenal of antiviral agents available for medical use.

Career Highlights

Hansen has played a pivotal role in advancing pharmaceutical sciences throughout her career. Notably, she has contributed her expertise while working with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. Her extensive background equips her with the skills and knowledge essential for pioneering new technologies in the health sector.

Collaborations

Throughout her journey, Jutta Hansen has collaborated with prominent professionals in her field, including Arnold Paessens and Dieter Habich. These collaborations fostered a creative environment that encouraged the exchange of ideas and innovations, further propelling her contributions to the industry.

Conclusion

Jutta Hansen is a prominent figure in the realm of inventions and innovations, particularly in antiviral research and development. Her dedication and pioneering spirit continue to inspire the next generation of inventors striving to make significant impacts in the health sector. As her journey evolves, her contributions remain vital in the fight against viral infections.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.